Address: No. 28, Mehta Vora Chamber, Mahendra Mansion, Babu Genu RoadMumbai – 400 002, Maharashtra, India
Tel: 91 22 26101320
Web: http://www.apexdrugs.com/
Started in 1979 as an Importer for Bulk Drug and API’s, Today Apex Drug House has diversified into manufacturing of pharmaceutical formulations and is at the forefront in developing and marketing for International markets. Our products are manufactured in WHO GMP, NAFDAC, NDA and FDB certified facilities where various forms of pharmaceuticals like Tablets, Capsules, Syrups, Ointments, Lozenges, Dry Powder Injections, Liquid Injections, Ophthalmic solutions and Aerosols are manufactured. Additionally Apex also manufactures Herbals, Soft Gelatin Capsules, Lozenges and specialty products like Mosquito Repellents and Condoms. We focus on providing quality products and continually invest our time and resources in the quest to achieve higher levels of quality products and earned reputation from our clients.
Apex Drug House has a strong presence in regions like Latin America, South East Asia, CIS and African regions. With the know-how and the capacity of our plants we are close to our customers in important markets. We provide a worldwide supply chain, making sure that products will be available when and where they are needed. Our strong portfolio of products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world, regardless of geographic and socio-economic barriers.
Apex Drug House is a fully integrated pharmaceutical formulation company at the forefront in developing, manufacturing and marketing of formulations for International markets. Additionally Apex also manufactures Herbals, and specialty products like Mosquito Repellents and Condoms. Our strong portfolio of products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world.
Newly appointed commissioner of the Food & Drugs Administration (FDA) of the Indian state of Maharashtra, Dr. Pallavi Darade, shares her objectives to further consolidate the FDA’s positioning as a…
With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to the country’s vast population, two pioneering pharmaceutical multinationals – Novartis and Janssen –…
Kanchana TK, director general of the Organisation of Pharmaceutical Producers of India (OPPI), the association which represents the interests of research-based pharmaceutical companies in India, discusses regulatory reform and how…
Janmejay Vyas, chairman of the Dishman Group, shares the story of his success in establishing a trustworthy relationship with the strictest drug regulator in the world, the US FDA. Mr…
“From illness to wellness” – this is what Apollo Life is all about. Ariz Rizvi, president of Apollo Life, gives his insight into the current state of occupational and rehabilitative…
Sridhar Ranganathan, managing director of Allergan, explains how the affiliate revolutionized the ophthalmologic market in India and how it engages with the different stakeholders, ranging from government institutions to the…
Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign – and both Indian companies and multinationals implanted in the world’s second most populous…
A strong advocate for women’s health and the first managing director of Roche Diagnostics India to be under 40 years old, Dr. Shravan Subramanyam shares his insights on the Indian…
With his over 25 years’ experience in running growing businesses and establishing start-ups, Ranjit Madan, CEO of the Life Sciences Sector Skill Development Council (LSSSDC), explains the journey of the…
Dilip G Shah, secretary-general of the Indian Pharmaceutical Alliance (IPA) and member of the Expert Review Committee on Access to Medicine (ATM), discusses the association’s commitment to assisting the Indian…
A passionate advocate for reverse mentoring, Abbott India Limited’s managing director, Venu Ambati, discusses the productive investments that the company has made in India, and his intention to make digital…
India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the leading country in its region. Despite the prevalence…
See our Cookie Privacy Policy Here
